Concept Architecture
Concept
Theoretically, Two-Stage Meta-Analysis is a statistical approach in which treatment effects are estimated separately within each study before being combined across studies using conventional meta-analytic methods. It is most commonly applied in individual patient data (IPD) meta-analysis, allowing study-specific analyses to be performed prior to evidence synthesis. The method exists to preserve study-level estimation while enabling flexible pooling of treatment effects across multiple studies.
Mathematically, two-stage meta-analysis proceeds by first estimating a treatment effect and its variance for each study using an appropriate statistical model. In the second stage, these study-specific estimates are synthesised using fixed effect or random-effects meta-analysis, typically through inverse-variance weighting. The resulting pooled estimate incorporates within-study precision and, where appropriate, between-study heterogeneity.
In practice, two-stage meta-analysis is widely used in health technology assessment, comparative effectiveness research and systematic reviews involving individual patient data. It is particularly useful when study-specific analyses differ slightly or when investigators wish to retain familiar meta-analysis methods while benefiting from participant-level data. The pooled estimates frequently provide treatment-effect inputs for health economic models.
Purpose
Used to estimate treatment effects separately within each study before combining them into a pooled estimate using conventional meta-analysis techniques.
Mathematical Formulae
Primary Formula
Second-stage pooled estimate:
?? = (?w????) / ?w?
where:
- ?? = pooled treatment effect
- ??? = treatment effect estimated in study j
- w? = study weight
Supporting Formulae
Fixed effect weight:
w? = 1 / Var(???)
Random-effects weight:
w? = 1 / (Var(???) + ��)
Variance of pooled estimate:
Var(??) = 1 / ?w?
Related Mathematical Methods
- Individual Patient Data Meta-Analysis
- One-Stage Meta-Analysis
- Fixed Effect Meta-Analysis
- Random-Effects Meta-Analysis
- Inverse-Variance Weighting
- Mixed-Effects Regression
- Meta-Regression
Example
Participant-level data from 11 oncology trials are analysed separately within each trial using Cox proportional hazards regression to estimate hazard ratios. The resulting study-specific hazard ratios are subsequently pooled using a random-effects meta-analysis, producing an overall hazard ratio of 0.84 (95% confidence interval 0.76 to 0.93). The pooled estimate is incorporated into a partitioned survival model for health technology assessment.
Excel Implementation
| Function | Example Formula | Health Economics Application |
|---|---|---|
| SUMPRODUCT | =SUMPRODUCT(B2:B12,C2:C12)/SUM(B2:B12) | Calculate the pooled treatment effect from study-specific estimates |
| SUM | =SUM(B2:B12) | Calculate the total inverse-variance weight |
| SQRT | =SQRT(1/SUM(B2:B12)) | Calculate the pooled standard error |
| EXP | =EXP(A2) | Convert pooled log estimates to hazard ratios, odds ratios or risk ratios |
| CHISQ.DIST.RT | =CHISQ.DIST.RT(Q,df) | Assess heterogeneity before pooling study estimates |
VBA (Optional)
Automate extraction of study-specific treatment estimates and perform second-stage pooling using fixed effect or random-effects meta-analysis.
Sources
- Riley RD, Lambert PC, Abo-Zaid G. Meta-Analysis of Individual Participant Data: Rationale, Conduct and Reporting. BMJ. 2010.
- Stewart LA, Tierney JF. To IPD or Not to IPD? Advantages and Disadvantages of Systematic Reviews Using Individual Patient Data. Evaluation & the Health Professions. 2002.
- Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions.
- Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis.
- NICE. Health Technology Evaluation Manual.
- ISPOR Good Practice Reports.
Related Concepts (2)
Library
Publications
1
Network Meta-Analysis for Decision Making — Dias, Ades, Welton, Jansen & Sutton, 1st Edition ed., 2018 (John Wiley & Sons)
The definitive text on network meta-analysis (mixed treatment comparisons) for decision making, presenting a coherent Bayesian framework (implemented in WinBUGS) for synthesising evidence across multiple treatments, including inconsistency, bias adjustment, and use in cost-effectiveness models.
BookView source →
Frequently Asked Questions (6)
What is two-stage meta-analysis?
An individual patient data meta-analysis first analysing each study separately, then combining the resulting study-level estimates using standard methods.
Source: Stewart & Parmar 1993
What two steps does two-stage meta-analysis take with patient data?
Two-stage meta-analysis of individual patient data works in two steps: first each study's raw records are analysed separately to produce a summary estimate for that study, then those estimates are combined using standard meta-analysis methods, exactly as aggregate results would be. Keeping the studies separate at the first step makes the analysis simpler and more transparent than modelling all patients at once, while still drawing on the underlying data. Analyse each, then pool, is its sequence. Riley and colleagues (2010) describe this approach.
Source: Riley et al. 2010
How does two-stage meta-analysis work?
Two-stage meta-analysis works by, in the first stage, analysing each study's patient-level data separately to produce a summary estimate, such as a treatment effect, with its precision; and, in the second stage, combining these study-level estimates using standard meta-analysis, weighting by precision under a fixed-effect or random-effects model. This mirrors conventional meta-analysis but derives the study estimates from the raw data. So two-stage meta-analysis works by first summarising each study from its patient-level data and then pooling those summaries with established methods, separating the within-study analysis from the across-study combination into two distinct steps.
Source: Stewart & Parmar 1993
How does two-stage differ from one-stage meta-analysis?
Two-stage meta-analysis analyses each study's patient-level data separately and then combines the resulting summary estimates, while one-stage meta-analysis analyses the combined patient-level data from all studies together in a single model that accounts for the studies. The two-stage approach is often simpler and mirrors conventional meta-analysis, while the one-stage approach can be more flexible for modelling patient-level interactions and may be more efficient in some settings. So the two differ in whether the studies are summarised first and then pooled or modelled jointly in one step, both being approaches to individual patient data meta-analysis that often give similar results.
Source: Stewart & Parmar 1993
What are the advantages of two-stage meta-analysis?
The advantages of two-stage meta-analysis include its relative simplicity and transparency, since the second stage uses familiar meta-analysis methods and produces familiar outputs such as forest plots; its clear separation of within-study and between-study analysis, which makes heterogeneity easy to examine; and its avoidance of some complex modelling choices required by the one-stage approach. So two-stage meta-analysis is advantageous where a straightforward, transparent synthesis is wanted, giving results comparable to conventional meta-analysis while using patient-level data within each study, which is why it is a common and accessible way to conduct an individual patient data meta-analysis.
Source: Stewart & Parmar 1993
When is two-stage meta-analysis appropriate?
Two-stage meta-analysis is appropriate when patient-level data are available and a transparent, conventional-style synthesis is wanted, and when each study has enough data to be analysed reliably on its own to produce a stable summary estimate. Where studies are very small or the interest lies in modelling patient-level interactions in detail, the one-stage approach may be preferred. So two-stage meta-analysis is appropriate for many individual patient data syntheses, particularly where simplicity and familiar outputs are valued and the studies are individually analysable, with the choice between two-stage and one-stage depending on the data and the questions being addressed.
Source: Stewart & Parmar 1993
Trust Record
Verified by Dr Darrin Baines
British health economist
Professional identity: darrinbaines.org
Verification date: 4 Dec 2025
Content version: 1.0.0
Canonical Identity
- Term code
- HE-ES-ESM-065
Stable URI · Machine-readable · Resolvable · CC BY 4.0